Published in Curr Opin Hematol on January 01, 2000
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat Immunol (2010) 2.42
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes (2012) 1.52
Serum amyloid-A in Behçet's disease. Clin Rheumatol (2014) 1.47
Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood (2008) 1.46
Inflammatory bowel disease and systemic AA amyloidosis. Dig Dis Sci (2013) 1.43
Interaction of the tick immune system with transmitted pathogens. Front Cell Infect Microbiol (2013) 1.32
Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis. BMC Gastroenterol (2010) 1.13
Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Mol Med (2011) 1.13
mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm (2003) 1.11
An insight into the sialome of the soft tick, Ornithodorus parkeri. Insect Biochem Mol Biol (2007) 1.10
Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection. Infect Immun (2012) 1.05
Serum amyloid A: a novel biomarker for endometrial cancer. Cancer (2010) 1.05
Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol (2006) 1.03
Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proc Natl Acad Sci U S A (2002) 0.98
Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis. J Histochem Cytochem (2010) 0.98
Negative energy balance alters global gene expression and immune responses in the uterus of postpartum dairy cows. Physiol Genomics (2009) 0.96
The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma. Clin Exp Metastasis (2014) 0.95
A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab. Rheumatol Int (2008) 0.95
Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol (2014) 0.95
Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice. Hepatology (2013) 0.95
A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A. Am J Pathol (2010) 0.92
Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays. Mol Cell Proteomics (2011) 0.91
New inflammation-related biomarkers during malaria infection. PLoS One (2011) 0.91
Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A. PLoS Genet (2010) 0.91
Oral involvement in a case of AA amyloidosis: a case report. J Med Case Rep (2010) 0.89
Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2. J Biol Chem (2012) 0.89
Serum amyloid A stimulates macrophage foam cell formation via lectin-like oxidized low-density lipoprotein receptor 1 upregulation. Biochem Biophys Res Commun (2013) 0.88
Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion. PLoS One (2013) 0.88
Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance. Int J Obes (Lond) (2011) 0.88
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. Br J Cancer (2009) 0.88
Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis. Mol Biosyst (2013) 0.88
From bench to bedside and back again: translational research in autoinflammation. Nat Rev Rheumatol (2015) 0.87
Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10. BMC Genet (2005) 0.87
Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province. World J Gastroenterol (2004) 0.87
The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates. Mediators Inflamm (2006) 0.85
Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis. Clin Rheumatol (2014) 0.85
Gut transcriptome of replete adult female cattle ticks, Rhipicephalus (Boophilus) microplus, feeding upon a Babesia bovis-infected bovine host. Parasitol Res (2013) 0.85
A pertussis toxin sensitive G-protein-independent pathway is involved in serum amyloid A-induced formyl peptide receptor 2-mediated CCL2 production. Exp Mol Med (2010) 0.84
Characterization of the oligomerization and aggregation of human Serum Amyloid A. PLoS One (2013) 0.84
Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer. Biochem Biophys Res Commun (2011) 0.84
Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes. Mol Cancer (2011) 0.83
Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer. Protein Sci (2005) 0.83
Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer. Oncol Lett (2012) 0.83
Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis. Int Semin Surg Oncol (2005) 0.82
Amyloid nephropathy. Clin Kidney J (2014) 0.82
Zinc regulates the acute phase response and serum amyloid A production in response to sepsis through JAK-STAT3 signaling. PLoS One (2014) 0.82
Dual effect of serum amyloid A on the invasiveness of glioma cells. Mediators Inflamm (2013) 0.82
Serologic evaluation of clinical and subclinical secondary hepatic amyloidosis in rhesus macaques (Macaca mulatta). Comp Med (2009) 0.81
Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 during and after delivery. Mediators Inflamm (2005) 0.81
Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease. Exp Mol Pathol (2008) 0.81
Expression of serum amyloid A in uterine cervical cancer. Diagn Pathol (2014) 0.81
Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells. PLoS One (2016) 0.80
Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women. J Nutr (2014) 0.80
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H. PLoS One (2010) 0.80
Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases. Pediatr Nephrol (2015) 0.79
LL-37 inhibits serum amyloid A-induced IL-8 production in human neutrophils. Exp Mol Med (2009) 0.79
Interleukin-17A contributes to the expression of serum amyloid A in chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol (2012) 0.79
Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients. Clin Rheumatol (2007) 0.79
Secondary amyloidosis in ankylosing spondylitis. Rheumatol Int (2013) 0.78
Comparison of C-reactive protein and serum amyloid a protein in septic shock patients. Mediators Inflamm (2008) 0.78
Functional Module Analysis for Gene Coexpression Networks with Network Integration. IEEE/ACM Trans Comput Biol Bioinform (2015) 0.78
Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care (2012) 0.78
Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis. Biomed Res Int (2013) 0.78
S100A12 suppresses pro-inflammatory, but not pro-thrombotic functions of serum amyloid A. PLoS One (2013) 0.78
Serum amyloid A in the placenta and its role in trophoblast invasion. PLoS One (2014) 0.78
Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy. AIDS Res Hum Retroviruses (2014) 0.78
Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up. Clin Rheumatol (2012) 0.77
Cloning and characterisation of multiple ferritin isoforms in the Atlantic salmon (Salmo salar). PLoS One (2014) 0.77
Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation. Arterioscler Thromb Vasc Biol (2015) 0.77
Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks. FEBS Lett (2016) 0.77
Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives. Clin Dev Immunol (2012) 0.76
Decrease of circulating SAA is correlated with reduction of abdominal SAA secretion during weight loss. Obesity (Silver Spring) (2013) 0.76
A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76
Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization. Int J Ophthalmol (2014) 0.76
Comparison of the acute phase protein and antioxidant responses in dogs vaccinated against canine monocytic ehrlichiosis and naive-challenged dogs. Parasit Vectors (2015) 0.76
The diagnostic accuracy of acute phase proteins and proinflammatory cytokines in sheep with pneumonic pasteurellosis. PeerJ (2016) 0.75
The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome. J Assist Reprod Genet (2015) 0.75
The role of Vitamin D in immuno-inflammatory responses in Ankylosing Spondylitis patients with and without Acute Anterior Uveitis. J Med Life (2016) 0.75
Augmented Serum Amyloid A1/2 Mediated by TNF-induced NF-κB in Human Serous Ovarian Epithelial Tumors. Immune Netw (2017) 0.75
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma. Int J Cancer (2016) 0.75
Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivo. PLoS One (2017) 0.75
Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis. Oncotarget (2016) 0.75
Synovial fluid proteome in rheumatoid arthritis. Clin Proteomics (2016) 0.75
Ex vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils. J Immunol (2015) 0.75
Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia. Oncotarget (2016) 0.75
Acute fatal metabolic complications in alkaptonuria. J Inherit Metab Dis (2015) 0.75
Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis. Rheumatol Int (2017) 0.75
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood (1992) 2.81
Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem (1974) 2.69
Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med (1998) 2.21
Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin. Proc Natl Acad Sci U S A (1975) 1.84
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
The familial Mediterranean fever gene--cloned at last. N Engl J Med (1997) 1.62
Clinical problem-solving. Assembling a coherent story. N Engl J Med (1994) 1.40
Partial resistance to anticoagulation after streptokinase treatment for acute myocardial infarction. Am J Cardiol (1990) 1.40
Laparoscopic splenectomy for immune thrombocytopenic purpura. J Laparoendosc Surg (1996) 1.39
Fibrillar protein deposits with tubular substructure in a systemic disease beginning as cutis laxa. Arch Dermatol (1993) 1.38
MEFV mutations in Turkish patients suffering from Familial Mediterranean Fever. Hum Mutat (2000) 1.28
Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J Clin Invest (1985) 1.27
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26
Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J Histochem Cytochem (1998) 1.22
Morphologic, chemical, and immunologic studies of amyloid-like fibrils formed from Bence Jones Proteins by proteolysis. J Immunol (1973) 1.21
Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology (2001) 1.19
Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol (1979) 1.19
HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome. Am J Med (1987) 1.15
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res (2001) 1.11
Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant. Biol Chem Hoppe Seyler (1986) 1.09
Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis. Biochem J (1990) 1.08
Cerebrovascular involvement in systemic AA and AL amyloidosis: a clear haematogenic pattern. Virchows Arch (1999) 1.07
Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G) Am J Pathol (1996) 1.06
Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur J Immunol (1987) 1.06
Systemic leishmaniasis mimicking malignant histiocytosis. Cancer (1979) 1.05
Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity. Cancer Res (1986) 1.05
The formation of amyloid-like fibrils in vitro from Bence Jones Proteins of the VlambdaI subclass. J Immunol (1973) 1.04
Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series. Virchows Arch A Pathol Anat Histopathol (1992) 1.01
Beta 2-microglobulin, different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol Chem Hoppe Seyler (1987) 0.98
The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost (1984) 0.97
The classification of amyloid deposits in clinicopathological practice. Histopathology (1996) 0.97
Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type. Am J Clin Pathol (1992) 0.96
Gastrointestinal amyloid deposits in old age. Report on 110 consecutive autopsical patients and 98 retrospective bioptic specimens. Pathol Res Pract (1994) 0.96
Evidence for membrane-bound oligomerization of bacteriophage phi X174 lysis protein-E. J Biol Chem (1989) 0.96
Is the formation of AL-type amyloid promoted by structural peculiarities of immunoglobulin L-chains? Primary structure of an amyloidogenic lambda-L-chain (BJP-ZIM). Biol Chem Hoppe Seyler (1987) 0.96
Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res Cardiol (1992) 0.96
C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med (1984) 0.94
Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever. Blood (1984) 0.94
Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia. Am J Hematol (1980) 0.93
Immunohistochemical identification and crossreactions of amyloid-A fibril protein in man and eleven other species. J Comp Pathol (1984) 0.93
Primary structure of the variable part of an amyloidogenic Bence-Jones Protein (Mev.). An unusual insertion in the third hypervariable region of a human kappa-immunoglobulin light chain. Hoppe Seylers Z Physiol Chem (1982) 0.93
Effect of zinc therapy on neutrophil chemotaxis in psoriasis. Isr J Med Sci (1990) 0.93
Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultrastructural, and immunohistochemical studies. Am J Clin Pathol (1986) 0.92
Molecular diagnosis of FMF: lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol (2002) 0.91
Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by dimethylsulfoxide and retinoic acid. Cell Differ (1987) 0.90
Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series. Virchows Arch (1998) 0.90
Abnormal neutrophil chemotaxis in Gaucher disease. Br J Haematol (1993) 0.90
Inactivation of interleukin-8 by the C5a-inactivating protease from serosal fluid. Blood (1993) 0.90
Typing and subtyping of haptoglobin from native serum using disc gel electrophoresis in alkaline buffer: application to routine screening. Anal Biochem (1984) 0.89
Differential effect of isolated placental isoferritins on in vitro T-lymphocyte function. Br J Haematol (1985) 0.89
Amyloid kidney stones of uremic patients consist of beta 2-microglobulin fragments. Biochem Biophys Res Commun (1986) 0.89
A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis. Proc Natl Acad Sci U S A (1996) 0.89
Monoclonal antibodies against amyloid fibril protein AA. Production, specificity, and use for immunohistochemical localization and classification of AA-type amyloidosis. J Histochem Cytochem (1984) 0.89
Serum ferritin in hematologic malignancies. Am J Hematol (1980) 0.88
Prognostic factors in multiple myeloma: a retrospective study using conventional statistical methods and a computer program. Acta Haematol (1978) 0.88
Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils. J Lab Clin Med (1998) 0.88
Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease. Clin Neuropathol (1982) 0.87
Hodgkin's disease and subsequent chronic lymphocytic leukemia in a patient with breast carcinoma. Isr J Med Sci (1978) 0.87
Prevalence and causes of anemia in elderly hospitalized patients. Gerontology (1979) 0.87
[Rheumatoid arthritis and amyloidosis. Diagnostic significance of a soluble synovial protein with immunologic cross reaction with the amyloid-fibril protein A]. Verh Dtsch Ges Rheumatol (1978) 0.87
Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. N-terminal amino acid sequence after isolation from formalin-fixed tissue. Lab Invest (1983) 0.86
Effect of ozone on neutrophil function in vitro. Clin Lab Haematol (2001) 0.86
Immunoglobulin D myeloma and amyloidosis: immunochemical and structural studies of Bence Jones and amyloid fibrillar proteins. Blood (1975) 0.86
Disorders of neutrophil function. Blood Rev (1995) 0.86
Subcutaneous amyloid-tumor of beta-2-microglobulin origin in a long-term hemodialysis patient. Nephron (1989) 0.85
Hereditary amyloid polyneuropathy in north west Ireland. Brain (1987) 0.84
A chemotactic inhibitor in synovial fluid. Immunology (1983) 0.84
A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. Prostaglandins (1992) 0.83
Anticardiolipin antibodies in acute myeloid leukemia: prevalence and clinical significance. Am J Hematol (1998) 0.83
Organ-limited laryngeal amyloid deposits: clinical, morphological, and immunohistochemical results of five cases. Ann Otol Rhinol Laryngol (1992) 0.83
Bullous amyloidosis. Br J Dermatol (1985) 0.83
The effect of trichophytin and candidin on neutrophil chemotaxis. Mycoses (1988) 0.82
Immunochemical typing of amyloid deposits after microextraction from biopsies. Appl Pathol (1985) 0.82
Amyloid in a multiple sclerosis lesion in clearly of Alambda type. Acta Neuropathol (2000) 0.82
Progressive liver failure in a patient with adult Niemann-Pick disease associated with generalized AL amyloidosis. Virchows Arch (1995) 0.82
Clinical, morphologic, biochemical, and immunohistochemical aspects of dialysis-associated amyloidosis. ASAIO Trans (1987) 0.82
Correction of neutrophil chemotaxis defect in patients with Gaucher disease by low-dose enzyme replacement therapy. Am J Hematol (1993) 0.82
[Whipple's disease with reactive (AA) amyloidosis]. Dtsch Med Wochenschr (1993) 0.82
Arachidonic metabolism and radiation toxicity in cultures of vascular endothelial cells. Prostaglandins Leukot Essent Fatty Acids (1989) 0.82
Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy. Isr J Med Sci (1978) 0.81
Acute lymphoblastic leukemia. Association with vasopressin-responsive diabetes insipidus. Arch Intern Med (1980) 0.81
High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies. J Biol Chem (1990) 0.81
[Liver transplantation in familial amyloid polyneuropathy. Case report and review of the literature]. Internist (Berl) (1997) 0.80
Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant. Br Heart J (1993) 0.80
Significance of abnormal neutrophil chemotaxis in Gaucher's disease. Blood (1994) 0.80
Generalised AA-amyloidosis in a bat (Pipistrellus pipistrellus). Vet Pathol (1996) 0.80
Immunochemical typing of amyloid from tissue biopsies. Acta Histochem Suppl (1982) 0.80
Intestinal multinodular A lambda-amyloid deposition associated with extramedullary plasmacytoma in three dogs: clinicopathological and immunohistochemical studies. J Comp Pathol (1998) 0.80
Hypophosphatemia in a patient with lymphoma in leukemic phase. Arch Intern Med (1981) 0.80
Bone marrow necrosis as the only manifestation of disseminated carcinomatosis. Acta Haematol (1980) 0.80
Renal transplantation in amyloid nephropathy. Int Urol Nephrol (1989) 0.80
A C5a inhibitor in peritoneal fluid. J Lab Clin Med (1984) 0.79
Identification of lambda light chain amyloid in eight canine and two feline extramedullary plasmacytomas. J Comp Pathol (1997) 0.79
Hemorrhagic bullous amyloidosis. A histologic, immunocytochemical, and ultrastructural study of two patients. Arch Dermatol (1988) 0.79
Differential induction of monocytic functions by dibutyryl cyclic AMP and retinoic acid in a human monoblast cell line U937. Isr J Med Sci (1988) 0.79
Unilateral extended amyloidosis of the renal pelvis and ureter: a case report. Urol Int (1991) 0.79
Expression of a chronic granulomatous disease-like defect by fluoride-exhausted neutrophils. Blood (1982) 0.78
Plasma cell leukemia and myeloma: a scanning electron-microscopic study of cell surface features in six cases. Am J Clin Pathol (1981) 0.78
Isolation and fractionation of ferritin from human term placenta--a source for human isoferritins. Anal Biochem (1985) 0.78
Prevalence and causes of anemia in the elderly in Kiryat Shmoneh, Israel. Gerontology (1979) 0.78